XIVAR 15 MG Tablets: Advanced Anticoagulant for Clot Prevention

XIVAR 15 MG is an oral anticoagulant medication containing Rivaroxaban, a direct Factor Xa inhibitor. It is prescribed to prevent and treat various conditions related to blood clots, offering a crucial intervention for patients at risk of serious cardiovascular events. This medication works by blocking a key protein involved in blood clotting, thereby reducing the likelihood of clot formation.

Benefits of Use:

XIVAR 15 MG is highly effective in:

• Preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation.
• Treating deep vein thrombosis (DVT) and pulmonary embolism (PE).
• Preventing recurrent DVT and PE in adults.
• Preventing venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.
• Reducing the risk of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) or peripheral artery disease (PAD).

How to Use:

1. Always take XIVAR 15 MG exactly as prescribed by your doctor.
2. Swallow the tablet whole with a glass of water.
3. It is recommended to take XIVAR 15 MG (15 mg and 20 mg doses) with food to ensure proper absorption.
4. Try to take your medication at the same time each day to help you remember and maintain consistent drug levels.
5. Do not crush, chew, or split the tablets.
6. If you miss a dose, take it as soon as you remember on the same day. Do not take two doses to make up for a missed dose. Consult your doctor for specific instructions on managing missed doses.

Caution & Warnings:

• Bleeding Risk: XIVAR increases your risk of bleeding, which can be serious and potentially life-threatening. Report any signs of unusual bleeding (e.g., nosebleeds, bleeding gums, blood in urine or stools, severe bruising) to your doctor immediately.
• Drug Interactions: Inform your doctor about all medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins, as some can interact with Rivaroxaban and increase the risk of bleeding or reduce effectiveness. Avoid NSAIDs, aspirin, clopidogrel, and other anticoagulants unless specifically directed by your doctor.
• Kidney and Liver Impairment: Use with caution in patients with severe kidney or liver disease, as dosage adjustments may be necessary.
• Pregnancy and Breastfeeding: XIVAR is not recommended during pregnancy or breastfeeding due to the potential risk of harm to the fetus or infant. Discuss contraception options with your doctor if you are of childbearing potential.
• Surgery/Procedures: Inform your surgeon or dentist that you are taking XIVAR before any surgical or dental procedures, as it may need to be temporarily stopped.
• Spinal/Epidural Hematoma: Patients receiving spinal or epidural anesthesia or spinal puncture are at risk of developing a hematoma, which can result in long-term or permanent paralysis.

Ingredients:

Active Ingredient: Rivaroxaban 15 mg

Excipients: The tablet contains various inactive ingredients (e.g., cellulose microcrystalline, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, iron oxide red) that aid in the formulation and stability of the tablet.

Product Details:

• Dosage Form: Film-coated tablet
• Strength: 15 mg
• Package Size: 28 Tablets (in blister packs)
• Manufacturer: Spimaco
• Storage: Store at room temperature below 30°C, away from moisture and direct heat. Keep out of reach of children.